Transient Elastography and Variceal Bleeding

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

29 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transient elastography is a new non-invasive rapid and reproducible method, allowing evaluating liver fibrosis by measurement of liver stiffness.

The aim of our study is to evaluate if the liver stiffness can predict the recurrence of upper variceal bleeding in cirrhotic patients hospitalized for variceal rupture.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease

NCT01241227

Liver Fibrosis

COMPLETED

Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.

NCT01789008

Alcoholism Liver Disease Liver Fibrosis

COMPLETED NA

Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography

NCT01360892

Chronic Hepatitis B Chronic Hepatitis C

UNKNOWN

Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (Pan-CHESS1801)

NCT03778775

Compensated Liver Cirrhosis Gastroesophageal Varices Bleeding

UNKNOWN

Transient Elastography in Hepatectomy for Hepatocellular Carcinoma

NCT01441453

Surgery Hepatocellular Carcinoma

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bleeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fibroscan

Group Type EXPERIMENTAL

Fibroscan

Intervention Type DEVICE

transient elastography measure - Liver stiffness

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fibroscan

transient elastography measure - Liver stiffness

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent form signed
* Social security affiliation
* Variceal bleeding with hematemesis or melena within 24 hours of inclusion
* Age \> 18 years
* Scheduled to undergo endoscopy within 24 hours of hospital admission

Exclusion Criteria

* Hepatocarcinoma
* Upper Gastro Intestinal bleeding for other causes than variceal bleeding
* Concomitant disease with a life expectancy of less than 45 days
* Rebleeding within 24 hours after first endoscopy
* Technical failure of transient elastography

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No